{"id":634026,"date":"2026-07-11T23:50:00","date_gmt":"2026-07-11T23:50:00","guid":{"rendered":"https:\/\/buglecall.org\/?p=634026"},"modified":"2026-07-11T23:50:00","modified_gmt":"2026-07-11T23:50:00","slug":"darpas-chilling-pre-covid-blueprint-predict-manufacture-deploy-pandemics-on-demand-2","status":"publish","type":"post","link":"https:\/\/buglecall.org\/?p=634026","title":{"rendered":"DARPA’s Chilling Pre-COVID Blueprint: Predict, Manufacture, & Deploy Pandemics On Demand"},"content":{"rendered":"

DARPA’s Chilling Pre-COVID Blueprint: Predict, Manufacture, & Deploy Pandemics On Demand<\/span><\/p>\n

\n

Authored by\u00a0Jon Fleetwood<\/a><\/u>, via\u00a0Substack<\/u><\/a>,<\/em><\/p>\n

A sprawling, multi-institution effort for “predicting” future pathogen characteristics, developing vaccines “in advance of need,” and building the very systems intended to validate those predictions.<\/em><\/strong><\/p>\n

\"\"<\/a><\/p>\n

The Defense Advanced Research Projects Agency (DARPA) spent the early 2010s constructing what may have been the most ambitious predictive vaccine-development infrastructure ever attempted: a sprawling, multi-institution effort designed to determine the future characteristics of purported pathogens before they emerged and ultimately use those predictions to develop drugs and vaccines before they were needed.<\/em><\/p>\n

The program, known as\u00a0PROPHECY<\/a>\u2014short for Pathogen Defeat\u2014was announced in 2010 under\u00a0Broad Agency Announcement DARPA-BAA-10-93<\/a>\u00a0and was managed by DARPA\u2019s Defense Sciences Office.<\/p>\n

DARPA itself described the vaccine-centric purpose of the program unambiguously.<\/p>\n

According to the agency: \u201cThe Prophecy (Pathogen Defeat) program will explore the evolution of viruses in the hopes of predicting viral mutations and ultimately developing drugs and vaccines in advance of need.\u201d<\/p>\n

The effort was not limited to coronaviruses, influenza, or any other single disease category.<\/p>\n

DARPA repeatedly stated that the goal was understanding: \u201cthe natural evolution of any virus.\u201d<\/p>\n

The result was a massive architecture that brought together machine learning researchers, statisticians, bioinformaticians, computational biologists, laboratory scientists, surveillance specialists, universities, contractors, and national laboratories into a single \u201cpredictive\u201d framework.<\/p>\n

Yesterday, this website\u00a0reported<\/a>\u00a0that DARPA\u2019s PROPHECY program expanded into the laboratory of coronavirus researcher Ralph Baric years before the COVID-19 pandemic and nearly a decade before the DARPA\/DEFUSE proposal documented all three defining structural features of the SARS-CoV-2 spike protein prior to the outbreak.<\/p>\n

\"\"<\/a><\/p>\n

DARPA Wanted to Turn Vaccine Development from Reactive to Predictive<\/h2>\n

DARPA openly believed that existing vaccine development operated backwards.<\/p>\n

The agency described the modern pharmaceutical model as: \u201cobservational and reactive.\u201d<\/strong><\/em><\/p>\n

PROPHECY was intended to replace that model with one that was: \u201cpredictive and preemptive.\u201d<\/strong><\/em><\/p>\n

Rather than waiting for future purported disease threats to appear before beginning the process of characterization and countermeasure development, DARPA sought systems capable of determining the characteristics of future pathogen populations in advance.<\/p>\n

Everything in PROPHECY flowed from that objective.<\/p>\n

Building the Blueprint Before the Pathogen<\/h2>\n

DARPA\u2019s ambitions extended far beyond outbreak forecasting.<\/p>\n

The agency stated: \u201cDARPA seeks to achieve the ability to successfully predict the natural evolution of any virus, via platforms and algorithms which are capable of monitoring rare advantageous viral events\u2026\u201d<\/strong><\/em><\/p>\n

The program sought systems capable of determining:<\/p>\n